Feb 9, 2023
Who’s ready for a beach date?
chapter 5 of watch your back anthony bridgerton is coming soon (tomorrow evening pst hopefully).
catch up here!
An Archive of Our Own, a project of the Organization for Transformative Works
seen from China
seen from Peru
seen from Türkiye
seen from United States
seen from India
seen from United States
seen from United States
seen from Türkiye
seen from United States
seen from Brazil
seen from Russia
seen from Romania
seen from United States
seen from Austria
seen from Malaysia
seen from Malaysia
seen from Türkiye
seen from Malaysia
seen from Canada
seen from United States
Who’s ready for a beach date?
chapter 5 of watch your back anthony bridgerton is coming soon (tomorrow evening pst hopefully).
catch up here!
An Archive of Our Own, a project of the Organization for Transformative Works
Abiomed (ABMD): A look at what lies ahead for this medical device company
Abiomed (ABMD): A look at what lies ahead for this medical device company
Shares of Abiomed Inc. (NASDAQ: ABMD) were down 4% in afternoon trade on Wednesday. The stock has dropped 22% over the past three months and 10% in the past one week. The company reported its third quarter 2020 earnings results last Thursday, beating earnings estimates but missing on revenue.
The stock was hurt by the revenue miss as well as by misleading reports by some researchers over the…
View On WordPress
Abiomed, Inc. (NASDAQ: ABMD): Q3 2020 Earnings Snapshot
Abiomed, Inc. (NASDAQ: ABMD): Q3 2020 Earnings Snapshot
— Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported net income of $69.2 million or $1.51 per share for the third quarter of 2020, vs. $1.09 per share expected.
— Revenue increased 10% annually to $221.6 million during the three-month period, vs. $226.99 million expected
— US revenue rose 8% to $185.6 million, while overseas revenue moved up 29% to $36 million
— Third-quarter…
View On WordPress
Abiomed misses Q1 2020 estimates; stock plunges
Abiomed misses Q1 2020 estimates; stock plunges
Abiomed (NASDAQ: ABMD) slipped more than 10% in the pre-market session as the company missed first quarter 2020 results. GAAP net income was $88.9 million, or $1.93 per diluted share compared to $90.1 million or $1.95 per share in the prior-year quarter. Revenue rose 15.4% to $207.7 million, but missed analysts prediction of $210.69 million.
“In Q1, we implemented new training programs,…
View On WordPress
Abiomed to report Q4 2019 earnings results powered by Impella
Abiomed to report Q4 2019 earnings results powered by Impella
Abiomed (NASDAQ: ABMD) is scheduled to release its fourth quarter results today before the bell. Investors would be expecting the medical device company continues the momentum from the last quarter powered by its flagship product Impella, which is expected to boost earnings in the near future.
For the fourth quarter, analysts are expecting earnings to jump 35% to $1.08 per share and revenue to…
View On WordPress
Abiomed stock falls to yearly low
Abiomed stock falls to yearly low
Abiomed Inc. (NASDAQ: ABMD) stock fell to a yearly low of $270.25 on Thursday. Investors remained concerned about the future of the provider of temporary mechanical circulatory support devices. However, a unique product portfolio and robust demand for its Impella line of products could be beneficial for the company.
The data from the company’s flagship Impella heart pump showed a significant…
View On WordPress
Align Tech (ALGN:NAS) Fundamental Valuation Report
Align Tech (ALGN:NAS) Fundamental Valuation Report
Fundamental Valuation Report
Align Tech(ALGN:NAS) Healthcare:Medical Devices
This Report was generated using the…
View On WordPress
With Above Average Volumes, ABIOMED, Inc. (Nasdaq:ABMD) Closing At $337.86
With Above Average Volumes, ABIOMED, Inc. (Nasdaq:ABMD) Closing At $337.86
ABIOMED, Inc. (Nasdaq:ABMD)
November 12th, 2018 Amidst falling markets ABIOMED, Inc. fell $67.31 Monday which equals a 16.61% decline, closing at $337.86. Despite the drop in value, trading volumes were solid at 243% of normal which can indicate investor opportunities. (more…)
View On WordPress